Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations

BACKGROUND: Transfusion of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) convalescent plasma is a promising treatment for severe coronavirus disease 2019 (COVID‐19) cases, with success of the intervention based on neutralizing antibody content. Measurement by serologic correlates with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jungbauer, Christof, Weseslindtner, Lukas, Weidner, Lisa, Gänsdorfer, Simon, Farcet, Maria R., Gschaider‐Reichhart, Eva, Kreil, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536978/
https://www.ncbi.nlm.nih.gov/pubmed/32978802
http://dx.doi.org/10.1111/trf.16119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536978/
https://www.ncbi.nlm.nih.gov/pubmed/32978802
http://dx.doi.org/10.1111/trf.16119

Ejemplares similares